BioStock: DanCann signs distribution agreement with Tetra Bio-Pharma
Last week, DanCann Pharma signed a letter of intent with Canadian Tetra Bio-Pharma for the exclusive distribution rights for cannabinoid-based medicines in the Nordics and Germany. BioStock reached out to board member Per Wester to find out more.
Read the full interview with Per Wester at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/